SOUTHERN RESEARCH INSTITUTE

Southern Research Institute specializes in preclinical drug discovery, infectious disease modeling, and translational research across the physical, engineering, and life sciences. The contractor delivers end-to-end support for therapeutic development, including hit-to-lead progression, pharmacokinetic analysis, in vitro screening, and medicinal chemistry synthesis for antiviral and antimicrobial agents. Their technical expertise spans the development of preclinical models—particularly in ferrets and rodents—for evaluating vaccines and therapeutics against influenza, HIV, and other pathogens. They conduct specialized biological testing, compound optimization, and candidate product characterization to advance candidates from discovery through IND-enabling studies, with a strong focus on infectious disease and public health threats. The organization maintains a deep, long-standing relationship with the Department of Health and Human Services, primarily supporting agencies such as NIH and BARDA through contract-based research in antiviral development, vaccine evaluation, and drug metabolism studies. Their work consistently aligns with HHS priorities in pandemic preparedness, antimicrobial resistance, and biodefense, demonstrating a pattern of sustained engagement on mission-critical public health initiatives. Southern Research Institute’s industry focus centers on research and development in biotechnology and life sciences, with primary activity in NAICS 541714 and 541715. They operate at the intersection of medicinal chemistry, virology, and pharmacology, serving as a specialized R&D partner for government-funded therapeutic pipelines. Their market positioning is defined by niche expertise in infectious disease models and early-stage drug development, distinguishing them as a trusted provider for complex, high-stakes biomedical research. As a non-profit research institute headquartered in Birmingham, Alabama, Southern Research Institute operates under an 8H entity structure and holds no federal certifications beyond its institutional standing. With no physical presence outside its primary location, the organization is deeply embedded in the federal biomedical research ecosystem, leveraging its scientific infrastructure and technical workforce to support national health security objectives.